Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session



  • OpGen, Inc. OPGN shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.
  • Netcapital Inc. NCPL shares jumped 100% to $2.77 following Q2 results. Netcapital posted Q2 earnings of $0.04 per share on sales of $1.78 million.
  • Onion Global Limited OG gained 65% to $0.33.
  • Jiuzi Holdings, Inc. JZXN shares jumped 46.7% to $0.2171.
  • Faraday Future Intelligent Electric Inc. FFIE rose 33.3% to $0.6119 after surging over 55% on Monday. Faraday Future Intelligent Electric recently appointed FF China CEO Xuefeng (XF) Chen as Global CEO of the company
  • BeyondSpring Inc. BYSI jumped 31% to $0.9995 after the company presented data with plinabulin for the prevention of docetaxel-induced neutropenia in patients with non-small cell lung cancer and breast cancer at three medical conferences.
  • Fluence Energy, Inc. FLNC shares gained 28% to $22.05 after the company reported better-than-expected Q4 sales.
  • Shineco, Inc. SISI jumped 27% to $1.6518 after the company announced its subsidary was granted a USPTO patent and FDA marketing approval for its in-situ fecal specimen sampling device.
  • Gritstone bio, Inc. GRTS gained 27% to $3.2807. Gritstone bio was granted two new US patents for self-amplifying mRNA.
  • Prenetics Global Limited PRE rose 27% to $2.35. Prenetics recently announced a $20 million buyback.
  • SenesTech, Inc. SNES gained 26% to $3.13.
  • Magenta Therapeutics, Inc. MGTA gained 25.2% to $1.44 after the company highlighted updated data from the ongoing MGTA-117 Phase 1/2 dose-escalation trial at the American Society of Hematology 2022 Annual (ASH) Meeting.
  • Grom Social Enterprises, Inc. GROM rose 24.8% to $1.65.
  • ClearSign Technologies Corporation CLIR jumped 24.8% to $0.69.
  • Moderna, Inc. MRNA surged 22.8% to $202.86 after the company and Merck announced mRNA-4157/V940 in combination with KEYTRUDA, met the primary efficacy endpoint in the Phase 2b KEYNOTE-942 trial.
  • Schrödinger, Inc. SDGR rose 22.6% to $20.88.
  • Dada Nexus Limited DADA gained 21.7% to $8.02. Shares of Chinese companies traded higher following the recent easing of Covid restrictions in China, which has helped increase travel activity.
  • MamaMancini's Holdings, Inc. MMMB rose 21.4% to $1.5308 following better-than-expected Q3 results.
  • Ventyx Biosciences, Inc. VTYX rose 21.4% to $34.70 after gaining over 5% on Monday.
  • Rallybio Corporation RLYB shares climbed 19.8% to $10.43. JP Morgan, last week, initiated coverage on Rallybio with an Overweight rating and announced a price target of $21.
  • ACM Research, Inc. ACMR gained 19.6% to $10.43.
  • Wave Life Sciences Ltd. WVE gained 19.4% to $4.3115. Wave Life Sciences and GSK plc have announced a strategic collaboration to advance oligonucleotide therapeutics, including Wave's preclinical RNA editing program targeting alpha-1 antitrypsin deficiency, WVE-006.
  • Kaspien Holdings Inc. KSPN rose 19.1% to $0.8799.
  • Entrada Therapeutics, Inc. TRDA jumped 18% to $19.16. Vertex Pharmaceuticals and Entrada Therapeutics recently announced a global collaboration focused on discovering and developing intracellular Endosomal Escape Vehicle (EEV) therapeutics for myotonic dystrophy type 1 (DM1).
  • Summit Therapeutics Inc. SMMT gained 16.6% to $3.29.
  • 180 Life Sciences Corp. ATNF rose 15.5% to $0.3101.
  • National Western Life Group, Inc. NWLI gained 14.8% to $277.01.
  • 2U, Inc. TWOU gained 14.1% to $7.95.
  • Phathom Pharmaceuticals, Inc. PHAT jumped 13.1% to $11.38.
  • Ribbon Communications Inc. RBBN surged 12.5% to $2.98.
  • Gaotu Techedu Inc. GOTU gained 12% to $1.87. Gaotu Techedu, last month, reported a third-quarter FY22 sales decline of 45.6% year-on-year to RMB606.2 million ($85.21 million).
  • Mullen Automotive, Inc. MULN jumped 11.5% to $0.2152 after the company announced it signed its first U.S. dealer partner.
  • Pinterest, Inc. PINS climbed 10.6% to $26.12. Piper Sandler upgraded Pinterest from Neutral to Overweight and raised the price target from $25 to $30.
  • ARS Pharmaceuticals, Inc. SPRY gained 10.1% to $7.84 after SVB Leerink initiated coverage on the stock with an Outperform rating and a $14 price target.
  • Angi Inc. ANGI gained 9.7% to $2.3250 after Citigroup initiated coverage on the stock with a Buy rating and a $2.60 price target.
  • Pardes Biosciences, Inc. PRDS rose 9.6% to $1.26. JMP Securities initiated coverage on Pardes Biosciences with a Market Outperform rating and announced a price target of $9.
  • MediaCo Holding Inc MDIA rose 5.3% to $1.1485 after the company said it has divested the assets of Fairway Outdoor LLC to Lamar Advertising Company for $78.6 million.
  • Oracle Corporation ORCL gained 3% to $83.69 after the company reported better-than-expected results for its second quarter on Monday.


  • Quotient Limited QTNT fell 46% to $0.37. Quotient announced intent to voluntary delist from the Nasdaq Global Market.
  • Argo Blockchain plc ARBK shares fell 38.1% to $0.4246. Argo Blockchain recently announced a November operational update..
  • Avaya Holdings Corp. AVYA dropped 38% to $0.7149. Avaya disclosed certain information related to ongoing constructive discussions with financial stakeholders.
  • Midatech Pharma plc MTP fell 30% to $1.17. Midatech Pharma PLC proposed acquisition of Bioasis Technologies Inc.
  • China Jo-Jo Drugstores, Inc. CJJD shares dipped 29% to $5.05 after gaining around 115% on Monday.
  • Getaround, Inc. GETR fell 28.8% to $1.46 after dropping 32% on Monday. Getaround recently announced closing of business combination with InterPrivate II Acquisition Corp.
  • Edible Garden AG Incorporated EDBL fell 24.4% to $0.3225 after jumping over 59% on Monday.
  • Clovis Oncology, Inc. CLVS dropped 24% to $0.1521. Clovis Oncology voluntarily initiated a Chapter 11 proceeding in the U.S. Bankruptcy Court and will seek to sell its assets through a court-supervised sales process.
  • Aptevo Therapeutics Inc. APVO fell 23.2% to $3.00. Aptevo Therapeutics shares surged 14% on Monday after the company announced that APVO436, in combination with venetoclax and azacitidine, achieved a 100% clinical benefit rate in venetoclax treatment naïve AML patients.
  • Vanda Pharmaceuticals Inc. VNDA dropped 23% to $8.31.
  • Hyperfine, Inc. HYPR shares fell 21.9% to $0.9601. Hyperfine, on December 6, committed to organizational restructuring designed to decrease costs, create streamlined organization to support business, and has terminated approximately 13% of its global workforce.
  • Corvus Pharmaceuticals, Inc. CRVS dropped 20% to $0.80.
  • Harpoon Therapeutics, Inc. HARP dipped 20% to $1.1250. Harpoon Therapeutics recently announced it presented updated interim results at ASH 2022 for novel T cell engager HPN217 in relapsed/refractory multiple myeloma.
  • HTG Molecular Diagnostics, Inc. HTGM declined 19.8% to $0.8180.
  • Enzo Biochem, Inc. ENZ fell 19.4% to $1.49 following Q1 results.
  • Ambrx Biopharma Inc. AMAM shares fell 19.2% to $2.3099 after dipping 37% on Monday.
  • Adamas One Corp. JEWL shares fell 17.3% to $3.9250.
  • Curis, Inc. CRIS fell 17% to $0.5399. Curis shares announced additional clinical data from the TakeAim Leukemia study of emavusertib.
  • Bone Biologics Corporation BBLG dropped 16.8% to $0.2446.
  • SeqLL Inc. SQL fell 16.2% to $0.44.
  • The Lion Electric Company LEV fell 14.5% to $2.2810. Lion Electric reported pricing of 19,685,040 unit offering at $2.54 per unit.
  • Aerovate Therapeutics, Inc. AVTE fell 11.5% to $27.00. Aerovate Therapeutics, last month, posted a Q3 loss of $0.56 per share.
  • Nikola Corporation NKLA fell 11.5% to $2.0699.
  • Silvergate Capital Corporation SI dropped 11.5% to $18.80. JP Morgan maintained Silvergate Capital with an Overweight and lowered the price target from $50 to $30.
  • Engine Gaming and Media, Inc. GAME fell 9.3% to $0.9584 after jumping 95% on Monday. The company last Thursday announced it has entered into an agreement to combine with GameSquare Esports.
  • JetBlue Airways Corporation JBLU fell 8.6% to $7.03 as the company said it expects Q4 revenue per ASM at the low end of its guidance range.

Also check this out Ethereum Jumps Above This Major Level; Toncoin Emerges As Top Gainer.

Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasMid-Day MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!